Stockscreener 앱 받기
10.96
0.18%
-0.02
시장 영업 전:
10.97
0.010
+0.09%
전일 마감가:
$10.98
열려 있는:
$11
하루 거래량:
240.50K
Relative Volume:
0.58
시가총액:
$452.86M
수익:
$313.73M
순이익/손실:
$-31.39M
주가수익비율:
-14.43
EPS:
-0.7597
순현금흐름:
$-3.53M
1주 성능:
-0.18%
1개월 성능:
+6.30%
6개월 성능:
-7.98%
1년 성능:
+21.51%
1일 변동 폭
$10.92
$11.17
1주일 범위
$10.51
$11.35
52주 변동 폭
$8.36
$13.99
Angiodynamic Inc Stock (ANGO) Company Profile
명칭
Angiodynamic Inc
전화
(518) 798-1215
주소
14 PLAZA DRIVE, LATHAM
Compare ANGO vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
10.96 | 452.86M | 313.73M | -31.39M | -3.53M | -0.7597 |
ISRG
Intuitive Surgical Inc
|
451.38 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 개시 | Lake Street | Buy |
| 2024-04-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-09-25 | 개시 | H.C. Wainwright | Buy |
| 2023-04-17 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | 개시 | Oppenheimer | Perform |
| 2020-11-25 | 업그레이드 | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2017-04-07 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-03-30 | 다운그레이드 | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | 개시 | Barclays | Equal Weight |
| 2016-11-04 | 개시 | Cantor Fitzgerald | Buy |
| 2016-04-08 | 재개 | Piper Jaffray | Neutral |
| 2016-01-08 | 재확인 | Canaccord Genuity | Buy |
| 2015-11-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | 재확인 | Canaccord Genuity | Hold |
| 2012-06-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | 업그레이드 | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2010-09-08 | 재확인 | Wedbush | Neutral |
모두보기
Angiodynamic Inc 주식(ANGO)의 최신 뉴스
[8-K] ANGIODYNAMICS INC Reports Material Event - Stock Titan
Fair Value Assessment | AngioDynamics Inc. posts 117.8% EPS surprise beating loss estimatesEarnings Risk - Cổng thông tin điện tử tỉnh Tây Ninh
ANGO (AngioDynamics Inc.) notches massive Q1 2026 EPS beat, but shares fall 1.24 percent on slight year over year revenue decline.Social Trade Signals - Xã Thanh Hà
AngioDynamics Growing, But With More Noise Than The Street Likes (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Inc. Q3 2026 Financial Results: Revenue, Net Loss, and Key Financial Statements Overview - Minichart
AngioDynamics (NASDAQ: ANGO) Q3 2026 revenue up 9% while net loss grows - Stock Titan
AngioDynamics, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
AngioDynamics, Inc. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-04-02 - Seeking Alpha
AngioDynamics Inc (NASDAQ:ANGO) Beats Q3 Earnings Estimates and Raises Full-Year Guidance - ChartMill
AngioDynamics Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
AngioDynamics investors can watch Needham conference webcast April 14 - Stock Titan
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 18.0% - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Several Insiders Invested In AngioDynamics Flagging Positive News - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares in AngioDynamics (ANGO) - Stock Titan
AngioDynamics schedules April 2 earnings call before market open - Stock Titan
Bard And AngioDynamics Resolve 11-Year Patent Dispute - Law360
AngioDynamics, Inc. $ANGO Shares Acquired by Divisadero Street Capital Management LP - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update - MarketBeat
Veeva Systems' Stock Up After Q4 Earnings & Revenues Beat Estimates - Finviz
AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Decreases By 17.6% - MarketBeat
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 68.70% Potential Upside Amid Healthcare Innovations - DirectorsTalk Interviews
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates - Finviz
Hear AngioDynamics CEO Jim Clemmer live at Leerink healthcare conference - Stock Titan
Can AngioDynamics Inc. stock maintain growth trajectoryWeekly Trade Review & Fast Gain Stock Trading Tips - mfd.ru
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 72.62% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Is AngioDynamics Inc. a top pick in the sectorAnalyst Upgrade & Verified Technical Signals - mfd.ru
Bastion Asset Management Inc. Buys 304,960 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Will AngioDynamics Inc. benefit from rate cutsEarnings Risk Summary & Technical Confirmation Trade Alerts - mfd.ru
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth - Finviz
Is AngioDynamics Inc. stock influenced by commodity prices2025 Earnings Impact & Proven Capital Preservation Tips - mfd.ru
Essex Investment Management Co. LLC Increases Holdings in AngioDynamics, Inc. $ANGO - MarketBeat
Kevin Kotler discloses 5.9% AngioDynamics (ANGO) stake in 13G filing - Stock Titan
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect? - Finviz
Here's Why You Should Add Masimo Stock to Your Portfolio Now - Finviz
AngioDynamics summit spotlights tools for clots and tough heart infections - Stock Titan
Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now - Finviz
Reasons to Add AngioDynamics Stock to Your Portfolio for Now - Finviz
Is AngioDynamics Inc. stock a smart retirement pick2025 Trading Recap & Weekly Stock Performance Updates - Mfd.ru
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring An 81.88% Potential Upside - DirectorsTalk Interviews
Fed Watch: What is XPO Inc.’s market positionWall Street Watch & Smart Allocation Stock Tips - baoquankhu1.vn
Portfolio Update: Will AngioDynamics Inc stock benefit from M AEarnings Overview Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
RSI Check: Why is AngioDynamics Inc stock going down2025 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - GlobeNewswire Inc.
Treasury Yields: Will AngioDynamics Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
AngioDynamics Inc Presents at J.P. Morgan Healthcare Conference - TradingView
AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare ConferenceSlideshow - Seeking Alpha
AngioDynamics to lay off 54 workers in Glens Falls, Queensbury - timesunion.com
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts - Finviz
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) - Finviz
Angiodynamic Inc (ANGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
0.44%
자본화:
|
볼륨(24시간):